TEVA-TIMOLOL DIN 01947796
Health Canada record
| Active ingredient(s) | TIMOLOL MALEATE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C07AA06 TIMOLOL |
| Original market date | 31-Dec-1992 |
| Current status date | 18-May-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TIMOLOL MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00755850 | TIMOLOL | AA PHARMA INC | Tablet | TIMOLOL MALEATE 10 MG | Marketed |
| 00755869 | TIMOLOL | AA PHARMA INC | Tablet | TIMOLOL MALEATE 20 MG | Marketed |
| 00755842 | TIMOLOL | AA PHARMA INC | Tablet | TIMOLOL MALEATE 5 MG | Marketed |
| 00353922 | BLOCADREN TAB 10MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | TIMOLOL MALEATE 10 MG | Cancelled Post Market |
| 00495611 | BLOCADREN TAB 20MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | TIMOLOL MALEATE 20 MG | Cancelled Post Market |
| 00353914 | BLOCADREN TAB 5MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | TIMOLOL MALEATE 5 MG | Cancelled Post Market |
| 02044617 | NU-TIMOLOL TAB 10MG | NU-PHARM INC | Tablet | TIMOLOL MALEATE 10 MG | Cancelled Post Market |
| 02044625 | NU-TIMOLOL TAB 20MG | NU-PHARM INC | Tablet | TIMOLOL MALEATE 20 MG | Cancelled Post Market |
| 02044609 | NU-TIMOLOL TAB 5MG | NU-PHARM INC | Tablet | TIMOLOL MALEATE 5 MG | Cancelled Post Market |
| 01947818 | TEVA-TIMOLOL | TEVA CANADA LIMITED | Tablet | TIMOLOL MALEATE 10 MG | Cancelled Post Market |
| 01947826 | TEVA-TIMOLOL | TEVA CANADA LIMITED | Tablet | TIMOLOL MALEATE 20 MG | Cancelled Post Market |
| 00509353 | TIMOLIDE TAB | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | TIMOLOL MALEATE 10 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 02147483 | TIMOLOL SOLUTION - 0.5% | BDH INC. | Solution | TIMOLOL MALEATE 0.5 % | Cancelled Post Market |
| 00812447 | TIMOLOL-10 TAB 10MG | PRO DOC LIMITEE | Tablet | TIMOLOL MALEATE 10 MG | Cancelled Post Market |
| 00812439 | TIMOLOL-20 TAB 20MG | PRO DOC LIMITEE | Tablet | TIMOLOL MALEATE 20 MG | Cancelled Post Market |
| 00812455 | TIMOLOL-5 TAB 5MG | PRO DOC LIMITEE | Tablet | TIMOLOL MALEATE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 12362 | 2011-05-20 | New Drug Submission (NDS) | Manufacturer and product name change |
International API supply for TIMOLOL MALEATE
10 valid EDQM Certificates of Suitability from 10 holders. 14 active FDA Drug Master Files.
Request a quote for TEVA-TIMOLOL